Deutsche Bank
LBRX icon

Deutsche Bank’s LB Pharmaceuticals LBRX Stock Holding History

Deutsche Bank’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$780K Sell
20,317
-1,655
-8% -$68.4K ﹤0.01% 2384
2026
Q2 		$713K Buy
21,972
+6,613
+43% +$194K ﹤0.01% 2577
2026
Q1 		$379K Buy
15,359
+2,061
+15% +$47.5K ﹤0.01% 2718
2025
Q4 		$296K Buy
+13,298
New +$232K ﹤0.01% 2832

Other funds holding LBRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Meyer Handelman Company
Meyer Handelman Company Rye Brook, New York $3.49B AUM 26.82% 1-Year Est. Return

Deutsche Bank's LBRX Position: Q3 2026 in Review

Deutsche Bank reduced its LB Pharmaceuticals (LBRX) stake by 7.5% in Q3 2026, selling an estimated $68.4K and leaving 20,317 shares worth $780K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

Deutsche Bank first reported a position in LBRX in Q4 2025 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Deutsche Bank held 20,317 shares of LB Pharmaceuticals worth $780K as of Q3 2026.
  • Deutsche Bank sold 1,655 LB Pharmaceuticals shares in Q3 2026, an estimated $68.4K.
  • LB Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2384 holding.
  • Deutsche Bank first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 36 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.